Transgender children under 16 years old taking puberty blockers are at risk of poor mental health, according to a new analysis by UK scientists.
In a study (pdf) reexamining data on 44 children ages 12 to 15, researchers found that up to 34 percent of trans teens with gender dysphoria taking the puberty blocker triptorelin self-reported declined mental health. At the same time, up to 29 percent reported improvement, while 37 percent reported no change in mental health status.
